
Varnglim 2mg/500mg Tablet SR
Marketer
SB Lifesciences
Salt Composition
Glimepiride (2mg) + Metformin (500mg)
Overview Varnglim 2mg/500mg Tablet SR
Diabetol Duo 2mg/500mg Extended-Release Tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. Diabetol Duo should be ingested with food, consistently at the same time daily for optimal effectiveness. Dosage is determined individually by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial, even with controlled blood sugar, as discontinuation without medical consultation can elevate glucose levels, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication is part of a comprehensive diabetes management plan, incorporating a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle modifications are integral to diabetes control. Hypoglycemia (low blood sugar) is a frequent side effect, characterized by sweating, lightheadedness, headache, and tremors. Learn to recognize these symptoms and treat them promptly using fast-acting glucose sources like sweets or juice. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Additional possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. Diabetol Duo is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician prior to commencing treatment. Pregnant or lactating women require medical consultation before use. Regular blood glucose monitoring is necessary, and your doctor might order blood tests to assess blood cell counts and liver function.
Uses of Varnglim 2mg/500mg Tablet SR
Managing type 2 diabetes
Major Benefits of Varnglim 2mg/500mg Tablet SR:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the Varnglim 2mg/500mg Tablet SR whole; avoid chewing, crushing, or fracturing the tablet. Consume it with a meal.
Common Side effects of Varnglim 2mg/500mg Tablet SR:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Varnglim 2mg/500mg Tablet SR:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Administer Varnglim 2mg/500mg Extended-Release tablets with a meal.
How Varnglim 2mg/500mg Tablet SR works:
Varnglim SR tablets (2mg/500mg) combine glimepiride and metformin to manage blood sugar. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Varnglim 2mg/500mg SR tablets with alcohol is inadvisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Varnglim 2mg/500mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against potential hazards prior to prescription. Seek medical advice.
Breast feedingUNSAFE
Extended-release Varnglim tablets (2mg/500mg) are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyCAUTION
Exercise caution when administering Varnglim 2mg/500mg SR tablets to individuals with impaired renal function; dosage modification may be necessary. Consult a physician for guidance. The use of Varnglim 2mg/500mg SR tablets is contraindicated in patients exhibiting severe kidney disease. Close monitoring of kidney function is recommended during treatment.
LiverCAUTION
Exercise caution when administering Varnglim 2mg/500mg SR tablets to individuals with hepatic impairment. Dosage modification of Varnglim 2mg/500mg SR tablets may be necessary. Physician consultation is advised. For patients exhibiting mild to moderate liver dysfunction, initiation of Varnglim 2mg/500mg SR tablets should begin with a reduced dosage; however, its use is contraindicated in cases of severe liver disease.
What if you forget to take Varnglim 2mg/500mg Tablet SR :
Should you forget to take a Varnglim 2mg/500mg SR tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Varnglim 2mg/500mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
